GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Shiller PE Ratio

BGI Genomics Co (SZSE:300676) Shiller PE Ratio : 36.34 (As of May. 12, 2025)


View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Shiller PE Ratio?

As of today (2025-05-12), BGI Genomics Co's current share price is ¥50.51. BGI Genomics Co's E10 for the quarter that ended in Mar. 2025 was ¥1.39. BGI Genomics Co's Shiller PE Ratio for today is 36.34.

The historical rank and industry rank for BGI Genomics Co's Shiller PE Ratio or its related term are showing as below:

SZSE:300676' s Shiller PE Ratio Range Over the Past 10 Years
Min: 25.24   Med: 27.56   Max: 44.89
Current: 36.34

During the past years, BGI Genomics Co's highest Shiller PE Ratio was 44.89. The lowest was 25.24. And the median was 27.56.

SZSE:300676's Shiller PE Ratio is ranked worse than
70.13% of 77 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.22 vs SZSE:300676: 36.34

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BGI Genomics Co's adjusted earnings per share data for the three months ended in Mar. 2025 was ¥-0.128. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.39 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


BGI Genomics Co Shiller PE Ratio Historical Data

The historical data trend for BGI Genomics Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Shiller PE Ratio Chart

BGI Genomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 29.04

BGI Genomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 27.64 29.04 37.74

Competitive Comparison of BGI Genomics Co's Shiller PE Ratio

For the Diagnostics & Research subindustry, BGI Genomics Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BGI Genomics Co's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BGI Genomics Co's Shiller PE Ratio falls into.


;
;

BGI Genomics Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BGI Genomics Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=50.51/1.39
=36.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGI Genomics Co's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, BGI Genomics Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.128/115.1156*115.1156
=-0.128

Current CPI (Mar. 2025) = 115.1156.

BGI Genomics Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.000 99.000 0.000
201506 0.000 99.500 0.000
201512 0.000 100.600 0.000
201603 0.210 102.200 0.237
201606 0.200 101.400 0.227
201609 0.300 102.400 0.337
201612 0.210 102.600 0.236
201703 0.260 103.200 0.290
201706 0.270 103.100 0.301
201709 0.310 104.100 0.343
201712 0.200 104.500 0.220
201803 0.250 105.300 0.273
201806 0.270 104.900 0.296
201809 0.280 106.600 0.302
201812 0.166 106.500 0.179
201903 0.245 107.700 0.262
201906 0.249 107.700 0.266
201909 0.180 109.800 0.189
201912 0.016 111.200 0.017
202003 0.350 112.300 0.359
202006 3.769 110.400 3.930
202009 2.640 111.700 2.721
202012 -1.540 111.500 -1.590
202103 1.284 112.662 1.312
202106 1.362 111.769 1.403
202109 0.794 112.215 0.815
202112 0.106 113.108 0.108
202203 0.803 114.335 0.808
202206 0.676 114.558 0.679
202209 0.347 115.339 0.346
202212 0.129 115.116 0.129
202303 0.091 115.116 0.091
202306 0.031 114.558 0.031
202309 0.047 115.339 0.047
202312 0.057 114.781 0.057
202403 0.030 115.227 0.030
202406 0.013 114.781 0.013
202409 -0.344 115.785 -0.342
202412 -1.888 114.893 -1.892
202503 -0.128 115.116 -0.128

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BGI Genomics Co  (SZSE:300676) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BGI Genomics Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BGI Genomics Co Business Description

Traded in Other Exchanges
N/A
Address
21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Executives
Xu Qian Secretary Dong
Zhao Li Jian Directors, executives
Wang Yu Jue Directors, executives
Wang Jian Director
Liu Na Executives
Sun Ying Jun Director
Yin Ye Directors, executives
Du Yu Tao Directors, executives
Li Song Gang Supervisors
Hu Yu Jie Supervisors
Li Zhi Ping Executives
Chen Yi Qing Executives
Li Wen Qi Supervisors

BGI Genomics Co Headlines

No Headlines